Skip Navigation

European Heart Journal 1997 18(6):1007-1013;
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Katritsis, D.
Right arrow Articles by Rowland, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katritsis, D.
Right arrow Articles by Rowland, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European society of Cardiology

Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation

D. Katritsis, M. Hossein-Nia, A. Anastasakis, I. Poloniecki, D. W. Holt, A. J. Camm, D. E. Ward and E. Rowland

Department of Cardiological Sciences, St George's Hospital Medical School London SW17 0RE, U.K.

Received 7 January 1997; accepted 8 January 1997.

Correspondence: Dr D. Katritsis, Onassis Cardiac Surgery Center, 356 Sygrou Aye, Athens 176 74, Greece

Abstract

BACKGROUND: Although there remains particular concern about late malignant ventricular arrhythmias arising from myocardial damage induced by catheter ablation, the extent of myocardial injury resulting from clinical ablation procedures has not been fully studied. We conducted a prospective, controlled study to investigate the use of two newer markers of myocardial integrity, troponin-T concentration and creatine kinase isoforms, and a traditional marker, creatine kinase-MB concentration, in the assessment of myocardial injury following radiofrequency catheter ablation.

METHODS AND RESULTS: The study population consisted of 28 consecutive patients subjected to radiofrequency catheter ablation, and the control group comprised eight subjects undergoing diagnostic electrophysiology study. Prior to ablation and at 30 min, 1, 2, 6, and 12 h following the procedure, blood samples were taken to measure troponin-T and creatine kinase-MB concentrations, and the separation of creatine kinase isoforms (MM3/MM1 and MB2/MB1 ratios). The troponin-T concentration was above normal in all but two patients following radio-frequency ablation, and the MB2/MB1 ratio was raised in all but one patient following ablation, but was also abnormal in the pre-ablation samples in seven patients. The MM3/MM1 ratio failed to detect myocardial injury in 75% of patients. Of patients subjected to ablation, in only 36% was the creatine kinase-MB concentration raised at least once post-ablation. Thirty minutes post-ablation, there was a statistically significant difference between the control and patient groups only as regards troponin-T concentration. There was a significant association between troponin-T concentration immediately post-procedure, the number of discharges delivered (r=0·52, p=0·006) and maximum power used (r=0·48, p=0·009).

CONCLUSIONS: Our results indicate that catheter ablation inflicts a cumulative, detectable injury upon the myocardium. This injury can be quantitated by using newer analytical techniques, such as serial, post-ablation measurements of troponin-T concentration.

Key Words: Catheter ablation • troponin-T • creatine kinase isoforms


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
L. M. Haegeli, E. Kotschet, J. Byrne, D. C. Adam, E. E. Lockwood, R. A. Leather, L. D. Sterns, and P. G. Novak
Cardiac injury after percutaneous catheter ablation for atrial fibrillation
Europace, March 1, 2008; 10(3): 273 - 275.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
L. Babuin and A. S. Jaffe
Troponin: the biomarker of choice for the detection of cardiac injury
Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
D. S. Y. Lee, P. Dorian, E. Downar, M. Burns, E. L. Yeo, W. L. Gold, M. Paquette, W. Lau, and D. M. Newman
Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?
Europace, January 1, 2001; 3(3): 195 - 200.
[Abstract] [PDF]

Home page
 ChestHome page
G. Boriani, M. Biffi, V. Cervi, G. Bronzetti, G. Magagnoli, R. Zannoli, and A. Branzi
Evaluation of Myocardial Injury Following Repeated Internal Atrial Shocks by Monitoring Serum Cardiac Troponin I Levels
Chest, August 1, 2000; 118(2): 342 - 347.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. S. Manolis, V. Vassilikos, T. Maounis, H. Melita-Manolis, L. Psarros, A. Haliasos, and D. V. Cokkinos
Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: procedural correlates
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1099 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. Kallner, A. Öwall, and A. Franco-Cereceda
MYOCARDIAL OUTFLOW OF CALCITONIN GENE-RELATED PEPTIDE IN RELATION TO METABOLIC STRESS DURING CORONARY ARTERY BYPASS GRAFTING WITHOUT CARDIOPULMONARY BYPASS
J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 447 - 453.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.